RS63157B1 - Metode in vitro diferencijacije dopaminskih (mda) neurona srednjeg mozga - Google Patents
Metode in vitro diferencijacije dopaminskih (mda) neurona srednjeg mozgaInfo
- Publication number
- RS63157B1 RS63157B1 RS20220353A RSP20220353A RS63157B1 RS 63157 B1 RS63157 B1 RS 63157B1 RS 20220353 A RS20220353 A RS 20220353A RS P20220353 A RSP20220353 A RS P20220353A RS 63157 B1 RS63157 B1 RS 63157B1
- Authority
- RS
- Serbia
- Prior art keywords
- mda
- neurons
- methods
- vitro differentiation
- midbrain dopamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562169379P | 2015-06-01 | 2015-06-01 | |
US201562169444P | 2015-06-01 | 2015-06-01 | |
EP16804350.3A EP3303564B1 (en) | 2015-06-01 | 2016-06-01 | Methods of in vitro differentiation of midbrain dopamine (mda) neurons |
PCT/US2016/035312 WO2016196661A1 (en) | 2015-06-01 | 2016-06-01 | Methods of in vitro differentiation of midbrain dopamine (mda) neurons |
Publications (1)
Publication Number | Publication Date |
---|---|
RS63157B1 true RS63157B1 (sr) | 2022-05-31 |
Family
ID=57441792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20220353A RS63157B1 (sr) | 2015-06-01 | 2016-06-01 | Metode in vitro diferencijacije dopaminskih (mda) neurona srednjeg mozga |
Country Status (17)
Country | Link |
---|---|
US (2) | US10858625B2 (sr) |
EP (3) | EP3303564B1 (sr) |
JP (4) | JP6974180B2 (sr) |
KR (2) | KR20220020416A (sr) |
AU (2) | AU2016270793B2 (sr) |
CA (1) | CA2987617A1 (sr) |
DK (1) | DK3303564T3 (sr) |
ES (1) | ES2910032T3 (sr) |
HR (1) | HRP20220482T1 (sr) |
HU (1) | HUE058258T2 (sr) |
IL (2) | IL255992B (sr) |
LT (1) | LT3303564T (sr) |
PL (1) | PL3303564T3 (sr) |
PT (1) | PT3303564T (sr) |
RS (1) | RS63157B1 (sr) |
SI (1) | SI3303564T1 (sr) |
WO (1) | WO2016196661A1 (sr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3411048A4 (en) | 2016-02-05 | 2019-07-31 | Memorial Sloan-Kettering Cancer Center | METHOD FOR THE DISTINCTION OF PRECURSORS OF STEM CELLS FROM THE ECOTODERMAL DESCALING LINE |
EP4001403A1 (en) * | 2016-08-16 | 2022-05-25 | FUJIFILM Cellular Dynamics, Inc. | Methods for differentiating pluripotent cells |
KR20190141218A (ko) * | 2017-04-26 | 2019-12-23 | 메모리얼 슬로안 케터링 캔서 센터 | 사용 준비된 냉동보존 세포 |
EP3655774A1 (en) * | 2017-07-17 | 2020-05-27 | Miltenyi Biotec B.V. & Co. KG | A method for single cell protein expression profiling of floorplate mesencephalic dopaminergic progenitor cells |
WO2019032680A1 (en) * | 2017-08-08 | 2019-02-14 | Regents Of The University Of Minnesota | METHODS OF GENERATING AND USING ORGANOIDS AND ASSOCIATED CELLS |
JP2022534693A (ja) * | 2019-05-23 | 2022-08-03 | ザ マクリーン ホスピタル コーポレーション | パーキンソン病のための自家細胞置換療法 |
AU2020315932A1 (en) | 2019-07-25 | 2022-03-10 | Aspen Neuroscience, Inc. | Methods of identifying dopaminergic neurons and progenitor cells |
CA3152522A1 (en) * | 2019-08-29 | 2021-03-04 | Memorial Sloan-Kettering Cancer Center | Methods of generating and isolating midbrain dopamine neurons |
KR102288424B1 (ko) * | 2019-09-20 | 2021-08-11 | 한국생명공학연구원 | 직접 리프로그래밍을 통한 유도 도파민성 신경세포 전구체의 제조방법 |
MX2022011831A (es) | 2020-03-25 | 2023-01-04 | Sana Biotechnology Inc | Células neurales hipoinmunogénicas para el tratamiento de trastornos y afecciones neurológicas. |
US20230165909A1 (en) | 2020-04-21 | 2023-06-01 | Aspen Neuroscience, Inc. | Gene editing of lrrk2 in stem cells and method of use of cells differentiated therefrom |
WO2021216622A1 (en) | 2020-04-21 | 2021-10-28 | Aspen Neuroscience, Inc. | Gene editing of gba1 in stem cells and method of use of cells differentiated therefrom |
CN116635047A (zh) * | 2020-06-26 | 2023-08-22 | 米纳瓦生物技术公司 | 用于从多能干细胞衍生多巴胺能神经元的方法 |
AU2021297464A1 (en) * | 2020-06-26 | 2023-02-23 | Minerva Biotechnologies Corporation | Methods for deriving dopaminergic neurons from pluripotent stem cells |
JP2024513912A (ja) * | 2021-04-07 | 2024-03-27 | フジフィルム セルラー ダイナミクス,インコーポレイテッド | ドーパミン作動性前駆細胞(precursor cell)及び使用方法 |
WO2023004370A1 (en) | 2021-07-21 | 2023-01-26 | Aspen Neuroscience, Inc. | Aav-based modulation of gba1 and related compositions and uses thereof |
US20230081881A1 (en) | 2021-07-21 | 2023-03-16 | Aspen Neuroscience, Inc. | Transposon-based modulation of gba1 and related compositions and uses thereof |
WO2023086894A1 (en) | 2021-11-12 | 2023-05-19 | Axent Biosciences Inc. | Methods for production of functional neurons |
US20230377685A1 (en) | 2022-04-15 | 2023-11-23 | Aspen Neuroscience, Inc. | Methods of classifying the differentiation state of cells and related compositions of differentiated cells |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6312911B1 (en) | 1999-05-06 | 2001-11-06 | Frank Carter Bancroft | DNA-based steganography |
KR100903755B1 (ko) * | 2000-05-17 | 2009-06-18 | 제론 코포레이션 | 신경 선조세포 집단 |
JP2008511304A (ja) * | 2004-09-02 | 2008-04-17 | ニューロ セラピューティクス エービー | ドーパミンニューロンの増強産生に関する方法と材料 |
SI1835924T1 (sl) | 2004-12-23 | 2013-12-31 | Ethicon, Incorporated | Zdravljenje Parkinsonove bolezni in sorodnih obolenj z uporabo celic, pridobljenih post partum |
EP2422800A3 (en) | 2006-03-07 | 2013-03-06 | Geeta Shroff | Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation |
WO2008008266A2 (en) | 2006-07-07 | 2008-01-17 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Biohybrid elastomeric scaffolds and methods of use thereof |
WO2010096496A2 (en) | 2009-02-17 | 2010-08-26 | Memorial Sloan-Kettering Cancer Center | Methods of neural conversion of human embryonic stem cells |
EP2577318B1 (en) | 2010-05-25 | 2019-06-26 | Memorial Sloan-Kettering Cancer Center | Method of nociceptor differentiantion of human embryonic stem cells and uses thereof |
US20110296542A1 (en) | 2010-05-28 | 2011-12-01 | Kevin Ka-Wang Wang | Exogenous matrix-supported topical application of stem cells to organ surface |
AU2012332269B2 (en) | 2011-11-04 | 2018-05-31 | Memorial Sloan-Kettering Cancer Center | Midbrain dopamine (DA) neurons for engraftment |
US20150159135A1 (en) | 2012-06-15 | 2015-06-11 | Baylor College Of Medicine | Perineurium Derived Adult Stem Cells and Methods of Use |
JP6756610B2 (ja) | 2013-04-26 | 2020-09-16 | メモリアル スローン ケタリング キャンサー センター | 多分化能細胞および多能性細胞の分化を方向付けることによって発生させる皮質介在ニューロンおよびその他のニューロン細胞 |
KR101696874B1 (ko) * | 2013-07-31 | 2017-01-16 | 한국생명공학연구원 | 직접 리프로그래밍을 통한 유도 도파민성 전구세포 제조방법 |
US10017734B2 (en) * | 2013-08-06 | 2018-07-10 | Takeda Pharmaceutical Company Limited | Method for producing dopaminergic neurons |
SG11201601720RA (en) * | 2013-09-05 | 2016-04-28 | Univ Kyoto | New method for inducing dopamine-producing neural precursor cells |
KR102483685B1 (ko) | 2013-11-21 | 2023-01-03 | 메모리얼 슬로안 케터링 캔서 센터 | 인간 다능성 줄기 세포로부터 기능적 두개 기원판 유도체의 전문화 |
JP6718431B2 (ja) * | 2014-03-21 | 2020-07-08 | フジフィルム セルラー ダイナミクス,インコーポレイテッド | 中脳ドーパミン作動性ニューロンの生産およびその使用方法 |
-
2016
- 2016-06-01 LT LTEPPCT/US2016/035312T patent/LT3303564T/lt unknown
- 2016-06-01 CA CA2987617A patent/CA2987617A1/en active Pending
- 2016-06-01 EP EP16804350.3A patent/EP3303564B1/en active Active
- 2016-06-01 SI SI201631535T patent/SI3303564T1/sl unknown
- 2016-06-01 KR KR1020227003399A patent/KR20220020416A/ko active IP Right Grant
- 2016-06-01 ES ES16804350T patent/ES2910032T3/es active Active
- 2016-06-01 DK DK16804350.3T patent/DK3303564T3/da active
- 2016-06-01 HU HUE16804350A patent/HUE058258T2/hu unknown
- 2016-06-01 HR HRP20220482TT patent/HRP20220482T1/hr unknown
- 2016-06-01 PL PL16804350T patent/PL3303564T3/pl unknown
- 2016-06-01 RS RS20220353A patent/RS63157B1/sr unknown
- 2016-06-01 AU AU2016270793A patent/AU2016270793B2/en active Active
- 2016-06-01 KR KR1020177037050A patent/KR102358878B1/ko active IP Right Grant
- 2016-06-01 JP JP2017562028A patent/JP6974180B2/ja active Active
- 2016-06-01 WO PCT/US2016/035312 patent/WO2016196661A1/en active Application Filing
- 2016-06-01 EP EP22157782.8A patent/EP4070803A1/en active Pending
- 2016-06-01 EP EP22176877.3A patent/EP4079314A1/en active Pending
- 2016-06-01 PT PT168043503T patent/PT3303564T/pt unknown
-
2017
- 2017-11-22 US US15/820,941 patent/US10858625B2/en active Active
- 2017-11-29 IL IL255992A patent/IL255992B/en unknown
-
2020
- 2020-06-12 JP JP2020102332A patent/JP2020146060A/ja active Pending
- 2020-11-09 US US17/093,126 patent/US20210123018A1/en active Pending
-
2021
- 2021-12-20 JP JP2021205897A patent/JP2022031961A/ja not_active Withdrawn
-
2022
- 2022-03-20 IL IL291532A patent/IL291532A/en unknown
- 2022-09-09 AU AU2022228216A patent/AU2022228216A1/en active Pending
-
2023
- 2023-11-02 JP JP2023188483A patent/JP2023181494A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2910032T3 (es) | 2022-05-11 |
HUE058258T2 (hu) | 2022-07-28 |
JP2018522538A (ja) | 2018-08-16 |
IL291532A (en) | 2022-05-01 |
EP4079314A1 (en) | 2022-10-26 |
PL3303564T3 (pl) | 2022-05-09 |
JP2020146060A (ja) | 2020-09-17 |
HRP20220482T1 (hr) | 2022-07-08 |
LT3303564T (lt) | 2022-05-10 |
US20180094242A1 (en) | 2018-04-05 |
JP6974180B2 (ja) | 2021-12-01 |
US10858625B2 (en) | 2020-12-08 |
WO2016196661A1 (en) | 2016-12-08 |
EP3303564B1 (en) | 2022-02-23 |
AU2022228216A1 (en) | 2022-10-06 |
SI3303564T1 (sl) | 2022-07-29 |
EP4070803A1 (en) | 2022-10-12 |
KR20220020416A (ko) | 2022-02-18 |
KR102358878B1 (ko) | 2022-02-08 |
JP2023181494A (ja) | 2023-12-21 |
AU2016270793B2 (en) | 2022-06-09 |
AU2016270793A1 (en) | 2017-12-14 |
EP3303564A4 (en) | 2018-10-31 |
CA2987617A1 (en) | 2016-12-08 |
US20210123018A1 (en) | 2021-04-29 |
EP3303564A1 (en) | 2018-04-11 |
IL255992B (en) | 2022-04-01 |
PT3303564T (pt) | 2022-06-02 |
KR20180014743A (ko) | 2018-02-09 |
DK3303564T3 (da) | 2022-04-04 |
IL255992A (en) | 2018-01-31 |
JP2022031961A (ja) | 2022-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL291532A (en) | Processes for in vitro differentiation of midbrain dopamine neurons | |
EP3238481A4 (en) | Method and apparatus of latency measurement for lte-wlan aggregation | |
DK3119881T3 (da) | Production of midbrain dopaminergic neurons and methods for the use thereof | |
SG11201610052TA (en) | Photo-controlled removal of targets in vitro and in vivo | |
HK1257761A1 (zh) | 用於測量限制的配置的方法和裝置 | |
EP3128045A4 (en) | Cylinder plating apparatus and method | |
ZA201703398B (en) | Pharmaceutical composition and methods | |
HK1214767A1 (zh) | 片劑形式的藥物組合物及其製造方法 | |
HK1243400A1 (zh) | 維生素d2和d3的改進的生產方法 | |
PT3503885T (pt) | Composição farmacêutica e métodos de utilização | |
GB201513084D0 (en) | Apparatus for measure of quantity and associated method of manufacturing | |
GB201412554D0 (en) | In vitro mesodermal differentiation | |
HUP1400543A2 (hu) | Eljárás és köztitermék apixaban elõállítására | |
IL254732A0 (en) | In vitro preservation of therapeutic cells | |
HUP1500647A2 (en) | Intermediate of baricitinib and process for its preparation | |
GB201416858D0 (en) | Methods of in Vitro Oocyte Development | |
TWM490537U (en) | Structure of stand | |
ZA201608823B (en) | Processes for the preparation of azd5363 and novel intermediate used therein | |
GB201612453D0 (en) | Methods and apparatus for measuring deformation | |
EP3230440A4 (en) | Compositions and methods for neuronal differentiation of cells | |
GB201406801D0 (en) | MRI Apparatus and methods | |
GB2526175B (en) | Design method and apparatus for the manufacture of an article | |
GB2533406B (en) | Methods and apparatus for manufacture of ophthalmic lenses | |
AU2014904953A0 (en) | Compositions and methods for neuronal differentiation of cells | |
GB201403177D0 (en) | Preparation and analysis of iminosugar acids |